HIV-positive TB patients on ART (antiretroviral therapy) in Peru
Peru: HIV-positive TB patients on ART (antiretroviral therapy) was 57.0% in 2024. ◆ Volatile
Latest (2024)
57.0%
Change on year
up 1.8%
World rank
137th
of 144 countries
All-time high
87.0%
in 2012
All-time low
1.2%
in 2010
Years of data
20
2003–2024
HIV-positive TB patients on ART (antiretroviral therapy) in Peru, 2003–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Peru recorded 57.0% for hiv-positive tb patients on art (antiretroviral therapy) in 2024.
The figure is up 1.8% on the previous year and down 13.6% over ten years.
Over the whole period, hiv-positive tb patients on art (antiretroviral therapy) in Peru peaked at 87.0% in 2012 and was at its lowest, 1.2%, in 2010.
Peru ranks 137th of 144 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
HIV-positive TB patients on ART (antiretroviral therapy) in Peru, year by year
| Year | Value | Change |
|---|---|---|
| 2003 | 2.7% | — |
| 2006 | 48.0% | +1677.8% |
| 2007 | 2.8% | -94.2% |
| 2008 | 17.0% | +507.1% |
| 2009 | 18.0% | +5.9% |
| 2010 | 1.2% | -93.3% |
| 2011 | 68.0% | +5566.7% |
| 2012 | 87.0% | +27.9% |
| 2013 | 64.0% | -26.4% |
| 2014 | 66.0% | +3.1% |
| 2015 | 65.0% | -1.5% |
| 2016 | 69.0% | +6.2% |
| 2017 | 82.0% | +18.8% |
| 2018 | 51.0% | -37.8% |
| 2019 | 55.0% | +7.8% |
| 2020 | 53.0% | -3.6% |
| 2021 | 50.0% | -5.7% |
| 2022 | 53.0% | +6.0% |
| 2023 | 56.0% | +5.7% |
| 2024 | 57.0% | +1.8% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 17.7% | 2.7% | 48.0% | 5 |
| 2010s | 60.8% | 1.2% | 87.0% | 10 |
| 2020s | 53.8% | 50.0% | 57.0% | 5 |
Countries ranked near Peru
- 134 Bolivia, Plurinational State of 65.0% compare
- 135 Netherlands 61.0% compare
- 136 Brazil 59.0% compare
- 138 Indonesia 54.0% compare
- 139 Trinidad and Tobago 51.0% compare
- 140 Malaysia 39.0% compare
- 140 Uruguay 39.0% compare
More health data for Peru
- Un projection of annual infant deaths, annual growth rate -1.88 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5045 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,235 deaths per 1,000 people (2090)
- Number of infants who die before age 1 782 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 2 (2025)
- Population ages 00-04, female, annual growth rate -0.3081 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.038 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.302 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is hiv-positive tb patients on art (antiretroviral therapy) in Peru?
- Hiv-positive tb patients on art (antiretroviral therapy) in Peru was 57.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hiv-positive tb patients on art (antiretroviral therapy) recorded in Peru?
- The highest recorded value was 87.0% in 2012.
- What is the lowest hiv-positive tb patients on art (antiretroviral therapy) recorded in Peru?
- The lowest recorded value was 1.2% in 2010.
- How does Peru rank for hiv-positive tb patients on art (antiretroviral therapy)?
- Peru ranks 137th out of 144 countries with data for 2024.
- Is hiv-positive tb patients on art (antiretroviral therapy) rising or falling in Peru?
- Over the last ten years it is down 13.6%. The long-run trend across the full record is volatile.
- Where does this Peru data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).